Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation

Multiple myeloma (MM) is characterized by excessive aggregation of B-cell-derived malignant plasma cells in the hematopoietic system of bone marrow. Previously, we synthesized an innovative molecule named dihydrocelastrol (DHCE) from celast...

Полное описание

Библиографические подробности

Главные авторы:	Jin Shuhan, Li Bo, Zhang Bibo, Gao Xuejie, Jia Xinyan, Xu Li, Chang Shuaikang, Hu Ke, Wang Guanli, Xu Zhijian, Zhang Ting, Song Dongliang, Yang Guang, Wu Xiaosong, Zhu Huabin, Huang Cheng, Lu Yumeng, Shi Jumei, Zhu Weiliang, Chen Gege
Формат:	Artigo
Язык:	Inglês
Опубликовано:	China Science Publishing & Media Ltd. 2023-11-01
Серии:	Acta Biochimica et Biophysica Sinica
Предметы:	dihydrocelastrol multiple myeloma JAK2/STAT3 PSMB5 bortezomib resistance
Online-ссылка:	https://www.sciengine.com/doi/10.3724/abbs.2023260
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!